China Releases Action Plan to Advance Drug Split Manufacturing for Foreign Pharma Companies

China's Ministry of Commerce, National Development and Reform Commission, and Ministry of Finance released the "Foreign Investment Stabilization and Quality Enhancement Action Plan," which includes measures to support foreign investment in pharmaceutical industries. Key initiatives include expediting the development and implementation of pharmaceutical split production guidelines to facilitate foreign-owned pharmaceutical license holders in conducting cross-border split production of biologics and chemical drugs, as well as expanding pilot zones for biotechnology and foreign-invested hospital sectors. The plan also encourages insurance companies to expand coverage of innovative drugs and medical devices in commercial insurance products.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments